Applied DNA Sciences Featured in Scientific American

Article Spotlights Ability of SigNature DNA as an Anti-Counterfeiting Solution for the Pharmaceutical Industry


STONY BROOK, NY--(Marketwired - January 14, 2016) - Applied DNA Sciences, Inc. (NASDAQ: APDN)(Twitter: @APDN), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, was featured in an article in Scientific American on January 12.

The article, titled "Authentic Drugs Tagged with Plant DNA Could Help Snare Fake Meds," describes the global problem of counterfeit pharmaceuticals and says the company's SigNature DNA could be used to tag legitimate drugs with a unique signature derived from plant DNA. Stating that the technology has been successfully used in other industries and "could be a game changer for pharmaceuticals," the article notes the ability to track and identify drugs would be useful for pharmaceutical firms that currently spend millions of dollars annually to find and prosecute counterfeiters. The article additionally reports that Applied DNA Sciences has begun to discuss the use of the technology with pharmaceutical manufacturers.

To read the article in its entirety, please visit the following link:

http://www.scientificamerican.com/article/authentic-drugs-tagged-with-plant-dna-could-help-snare-fake-meds/

The article at the link above is provided for informational purposes only. Applied DNA Sciences, Inc. is not responsible for the content of the linked article.

About Applied DNA Sciences

Applied DNA Sciences makes life real and safe by providing biotechnology-driven solutions to help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Patented botanical DNA solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature DNA is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, for textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators.

Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW. 

Forward Looking Statements

The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, which is available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contact Information:

Investor Contact:
Debbie Bailey
631-240-8817 
debbie.bailey@adnas.com

Media Contact:
Susan Forman
Dian Griesel Int'l.
212-825-3210 
sforman@dgicomm.com

Program Contact:
James Hayward
CEO
631-240-8801
james.hayward@adnas.com
web:www.adnas.com
twitter: @APDN